You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 2, February 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Evaluation of Pharmacologic Agents on Composite Graft Survival

Kenneth K. Aden, MD; Merrill A. Biel, MD, PhD

Arch Otolaryngol Head Neck Surg. 1992;118(2):175-178.


Abstract

• This study assessed the efficacy of various pharmacologic agents in improving composite graft viability in 60 New Zealand white rabbits given bilateral auricular composite grafts. Treatments included methylprednisolone preoperatively and for 3 days postoperatively or for 7 days postoperatively only; chlorpromazine, dimethylsulfoxide, or superoxide dismutase preoperatively; or indomethacin preoperatively and for either 3 or 7 days postoperatively. Four treatment modalities yielded a statistically significant decrease in percentage of necrosis. Methylprednisolone, when given preoperatively and continued postoperatively, produced the greatest increase (77%) in composite graft tissue survival. Dimethylsulfoxide, chlorpromazine, and indomethacin for 3 days were also effective, but to a much lesser extent. It is speculated that these agents may help stabilize cell membranes during the anoxic phase of plasmic imbibition and minimize cellular edema until revascularization can occur.

(Arch Otolaryngol Head Neck Surg. 1992;118:175-178)



Author Affiliations

From the Department of Otolaryngology, University of Minnesota, Minneapolis.


Footnotes

Accepted for publication August 2, 1991.

Presented at the American Academy of Facial Plastic and Reconstructive Surgery, Toronto, Ontario, June, 1989.

Reprint requests to the Minneapolis Ear, Nose, and Throat Clinic, 2211 Park Ave S, Minneapolis, MN 55404 (Dr Biel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of hyperbaric oxygen to enhance auricular composite graft survival in the rabbit model.
Lewis et al.
Arch Facial Plast Surg 2006;8:310-313.
ABSTRACT | FULL TEXT  

Enhancement of Auricular Composite Graft Survival With Hyperbaric Oxygen Therapy
Renner et al.
Arch Facial Plast Surg 2002;4:102-104.
ABSTRACT | FULL TEXT  

Composite Graft Survival: An Auricular Amputation Model
Henrich et al.
Arch Otolaryngol Head Neck Surg 1995;121:1137-1142.
ABSTRACT  

Pharmacologic and Surgical Enhancement of Composite Graft Survival
Fann et al.
Arch Otolaryngol Head Neck Surg 1993;119:313-319.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.